Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma

Seminars in Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles